The goal of the CHOICES project is that low- and lower-middle income country immunization programs a) include and can sustain both inclusion and high coverage of pneumococcal, rotavirus, and HPV vaccines and b) are aligned with broad country health priorities for communicable disease prevention and control.
Recent experience under Rotavirus Accelerated Vaccine Introduction Network (RAVIN), as well as under complementary and related initiatives underway with global partners, has surfaced a number of gaps in the resources available to guide country immunization program decision-making, particularly for program optimization and comprehensive prioritization efforts.
RAVIN consortium is a cross-disciplinary partnership between the Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center (IVAC), John Snow, Inc. (JSI), and the U.S. Centers for Disease Control and Prevention (CDC).
RAVIN has provided technical support to eight Gavi-eligible countries—Afghanistan, Bangladesh, Benin, Cambodia, Democratic Republic of Congo, Lao PDR, Myanmar, and Nepal—across RVV introduction and product switch decision-making, Gavi application, introduction preparation, and implementation. Our consortium partners have honed a set of common values throughout the RAVIN project, which will continue through this new grant:
We strive to build lasting relationships to produce better health outcomes for all.
